[Quality of life as a target variable in oncologic clinical research].
The change of target variables in palliative cancer treatment led to a new evaluation of quality of life. Its use as a target variable to discriminate different therapies is problematic. Investigations with a patient-questionnaire assessing quality of life showed that the validity of this term is difficult to judge. At present it should be used in clinical research as an accompanying variable only.
Institut für Klinische Forschung Hamburg.
A
A
Schmidt
W
W
Weidenhammer
S
S
Groll
D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000523:psychology / Q000628:therapy*; D003863:Depression / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000523:psychology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000523:psychology; D011788:Quality of Life; D012803:Sick Role
Lebensqualität als Zielvariable der onkologisch-klinischen Forschung.